quences and detection of late gadolinium enhancement (LGE) which was used as a marker of early myocardial involvement. Results: Six (14%) patients had LGE, mainly involving apical, mid-basal inferoseptal and basal inferolateral segments. The presence of LGE was significantly higher in the group who had electrocardiographic abnormalities (29% vs. 4%, p <0.05). Of these 6 patients, 3 had regional wall motion abnormalities (2 with isolated apical dyskinesis and 1 with lateral hypokinesis). Only one patient showed oedema on STIR sequences suggestive of active inflammatory activity. With CMR as the method of reference, the ECG had a sensitivity of 83% and a negative predictive value of 96% to detect CCM. Conclusion: ECG proves to be a useful, inexpensive and globally available tool for the screening of CCM in asymptomatic patients but with proven myocardial involvement in the CRM.
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Introduction: In the current guidelines for the treatment of hypertrophic cardiomyopathy surgical myectomy is the preferred treatment option in young patients. Data comparing the efficacy of TASH in young patients do not exist in large series.
Aim of study:
To compare the outcome of TASH in young patients with older patients.
Methods:
To test this hypothesis we performed a retrospective analysis of all patients treated in our centre from 1997 until now and compared the younger patients (<40 years) with the rest of the collective.
Results:
In this period we treated 1200 patients in our centre with TASH (57±15 years, 14-93 years). 150 patients were younger than 40 years at the time of the procedure. They had a statistical significant higher diameter of the interventricular septum (23,4±5,3 vs. 21,1±3,6 mm p<0,01) and showed slightly higher LVOT gradients at rest before TASH (55,0±34,3 vs. 50,7±37,7 mmHg p=n.s.) and after provocation (124,7±48,5 vs. 119,9±55,4 mmHG p=0,05). In this group of younger patients a higher dosage of alcohol was used for the ablation (1,6±1,1 vs. 1,4±1,0 ml p=0,08). After 6 months no statistical significant difference could be observed between the younger patients and the rest of our collective for the reduction of gradients at rest (29,7±30,4 vs. 28 Purpose: The purpose of this study was to assess the natural course of patients with genotype-positive, left ventricular hypertrophy negative (G+/ LVH-) hypertrophic cardiomyopathy (HCM). Methods: From 2006-2013, 112 patients without LVH (maximal wall thickness < 15 mm) from a cohort of 327 HCM mutation carriers were identified through relative screening. In this group, 70 of G+/LVH-patients (age 40±12 years, 55% women) had > 1 echocardiographic evaluation and were included in this study. Fifty-seven (81%) patients had mutations in cardiac myosin binding protein (MYBPC3). Structural characteristics, systolic function and diastolic function were assessed by 2-D echocardiography. Eight patients with diastolic dysfunction at baseline were excluded from further analysis. Results: During 4.1±2 years (range 1.3-7.5 years) of follow-up, none of the patients developed LVH ≥15 mm and no cardiac events occurred. Twelve (19%) patients developed diastolic dysfunction at follow-up. In these patients left ventricular (LV) wall thickness, LV mass and left atrial (LA) volume were increased compared to patients without diastolic dysfunction (TABLE 1) . Only in patients with diastolic dysfunction did wall thickness increase during follow up (+ 1 mm vs. 0 mm, p = 0.049). Background: Doxorubicin (DOX), an anticancer anthracycline, is known to induce serious cardiotoxicity, which is believed to be mediated by oxidative stress and complex interactions with iron. However, the relations between iron metabolism and DOX-induced cardiotoxicity remain a matter of controversy. Methods: Firstly, we used an in vivo murine model of iron overloading (IO) where male C57BL/6 mice received during 3 weeks (D0-D20) a daily dextran-iron injection (15 mg/kg/day.) and then (D21) a single dose of 6 mg/kg DOX. We evaluated cardiac function with echocardiography, myocardial gene's expression, nitrooxidative stress levels and iron status. Secondly, the anti-proliferative activity of DOX, in combination with dextran-iron, was evaluated in vitro in cultures of cancerous cells (EMT-6) or cardiomyocytes (H9c2). Results: At D30, there was a significant decrease in left-ventricular ejection fraction (LVEF) in all groups of DOX-treated mice. In IO mice treated by DOX, the LVEF fall was not majored and there was no increase in atrial natriuretic peptide mRNA cardiac gene-expression. IO alone resulted in cardiac hypertrophy and up-regulation of b-myosin heavy-chain expression. In myocardial tissue, electron
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spin resonance spectroscopy revealed an increase in nitro-oxidative stress in IO groups. While 1 μM of DOX induced a significant reduction of EMT-6 or H9c2 cells proliferation, dextran-iron (125-1000 μg/mL) alone did not modify cell viability and did not impair DOX cytotoxicity. Conclusions: IO did not result in a significant increase in DOX cardiotoxicity neither in mice, nor in cardiomyocytes, and did not impair DOX capacity to inhibit cancerous cells proliferation. Purpose: Chagas disease (ChD) is endemic in Latin American countries, but has become a worldwide problem due to migration of infected individuals to developed countries, mostly in Europe and North America. Electrocardiography has been considered an essential exam to evaluate ChD patients. The objective of this study was to identify prevalent abnormalities in the electrocardiogram (ECG) and common associated conditions in patients with ChD. Methods: In this observational and retrospective study, all 12-lead standard digital electrocardiograms (ECGs) analyzed by cardiologists of a public telemedicine service in Brazil, from January to December 2011 were assessed. This service attends primary care of 658 cities in Minas Gerais province. ECGs were sent by remote professionals through internet to be analyzed by cardiologists who are trained and experienced in the analysis and interpretation of ECG. The prevalence of ECG abnormalities in patients who declared to have ChD was assessed. Results: During the study period, 264,324 patients were evaluated; 7590 were ChD patients (mean age 57.0±13.7 years, 64.1% women. Hypertension was the most frequent comorbidity, present in 61.3% of the ChD patients, followed by diabetes (9.1%) and dyslipidemia (6.9%). Family history of coronary disease was reported by 32.6% of the patients, and 10.7% referred smoking. Only 30.1% of the patients had normal ECGs. Regarding the rhythm, 86.9% of them had a normal sinus rhythm, 5.3% atrial fibrillation or flutter, 5.4% ventricular premature beats, 2.5% supraventricular premature beats and 3.5% were pacemaker users. Right bundle branch block (RBBB) was observed in 22.7% of the ECGs, left bundle block in 3.1% and left anterior hemiblock (LAH) in 22.5%.The presence of first degree atrioventricular block was found in 4.9%, second and third degrees in 0.2% each. There was electrocardiographic evidence of left ventricular and atrial hypertrophy in 3.6% and 2.5% of patients, respectively. Conclusion: In this large sample of primary care patients with ChD, there was a high prevalence of ECG abnormalities. As expected, the most common abnormalities were RBBB and LAH.
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